Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system

Pharmacol Biochem Behav. 1985 Jul;23(1):43-8. doi: 10.1016/0091-3057(85)90128-5.

Abstract

Methiothepin has been reported to induce an increase of specific binding sites for 3H-5TH 2-3 days following a single administration of a large dose. The present study was intended to ascertain whether methiothepin pretreatment would induce behavioral serotonergic supersensitivity, as assayed by evaluating head-twitch response to quipazine and L-5-hydroxytryptophan (L-5HTP). Methiothepin-pretreated rats exhibited a significantly reduced response after quipazine but not a significant change after L-5HTP. Such findings could be explained by considering that quipazine stimulates both serotonin and dopamine receptors and by hypothesizing that methiothepin also induced dopaminergic supersensitivity which hampered head-twitch behavior. Such an explanation was supported by the following findings. Rats tested 5 days after a large dose of haloperidol exhibited reduced head-twitch response to quipazine. Moreover, rats which had received a single administration of either haloperidol or methiothepin showed (1) more sustained spontaneous locomotor activity, and (2) enhanced stereotyped response to apomorphine.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5-Hydroxytryptophan / pharmacology
  • Animals
  • Dibenzothiepins / pharmacology*
  • Haloperidol / administration & dosage
  • Head
  • Male
  • Methiothepin / pharmacology*
  • Movement / drug effects*
  • Quinolines / pharmacology*
  • Quipazine / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine / drug effects*
  • Receptors, Serotonin / drug effects*
  • Synaptic Transmission / drug effects

Substances

  • Dibenzothiepins
  • Quinolines
  • Receptors, Dopamine
  • Receptors, Serotonin
  • Quipazine
  • Methiothepin
  • 5-Hydroxytryptophan
  • Haloperidol